Coronavirus Drug Discovery

Chukwuebuka Egbuna is a chartered chemist, a chemical analyst, and an academic researcher. He is a member of the Institute of Chartered Chemists of Nigeria (ICCON), the Nigerian Society of Biochemistry and Molecular Biology (NSBMB), the Society of Quality Assurance (SQA) (USA), and the Royal Society of Chemistry (RSC) (United Kingdom).
Egbuna is also an editor of new Elsevier series on Drug Discovery Update. The series includes books, monographs and edited collections from all areas of drug discovery, including emerging therapeutic claims for the treatment of diseases. He has been engaged in a number of roles at New Divine Favor Pharmaceutical Industry Limited, Akuzor Nkpor, Anambra State, Nigeria, and Chukwuemeka Odumegwu Ojukwu University (COOU) in Nigeria. He has collaboratively worked and published quite a number of research articles in the area of phytochemistry, nutrition and toxicology and related areas. He is a reviewer and editorial board member of various journals, including serving as a website administrator for the Tropical Journal of Applied Natural Sciences (TJANS), a journal of the faculty of Natural Sciences, COOU and as an advisory board member under toxicology for the book publisher, Cambridge Scholar Publishing. His primary research interests are in phytochemistry, nutrition and toxicology, food and medicinal chemistry, and analytical biochemistry.

1. Antiviral drug discovery from medicinal plants
2. Antiviral drug discovery from animals
3. Antiviral drug discovery from marine organisms
4. Antiviral drug discovery from microorganisms
5. Coronavirus virology, treatment and drug discovery update
6. Coronavirus outbreak: The COVID-19 episode and conspiracy theories
7. Covid-19 signs and symptoms, diagnosis and prevention strategies
8. Application of computational tools for coronavirus drug discovery
9. Application of nanotechnology in tackling COVID-19
10. Drug discovery update for respiratory viral diseases
11. Drug discovery update for gastrointestinal viral diseases
12. Drug discovery update for exanthematous viral diseases
13. Drug discovery update for hepatic viral diseases
14. Drug discovery update for cutaneous viral diseases
15. Drug discovery update for hemorrhagic viral diseases
16. Drug discovery update for neurologic viral diseases
17. Tools and assays in antiviral drug discovery
18. Systematic review on bioactives with the most potent antiviral properties